Stelara 130 MG/26 ML vial 26ML
Ended Awarded
- Contract number
- SPE2DX25F6AEC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,100
Award facts
- Contract value 100% obligated
- $10,099.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $10,099.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order covers the supply of Stelara 130 mg/26 ml vials, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order is scheduled for completion by September 16, 2025, with the product to be delivered to Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on equal footing with other qualified vendors.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Through this master contract vehicle, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facility needs worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a substantial contract portfolio encompassing branded and generic prescription drugs, biologics, vaccines, and medical consumables distributed to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AEC?
SPE2DX25F6AEC was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 25, 2025.
How much is contract SPE2DX25F6AEC worth?
The government has obligated $10,100 on SPE2DX25F6AEC.
Is contract SPE2DX25F6AEC an order under another contract?
Yes. SPE2DX25F6AEC is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEC competed?
The extent of competition for SPE2DX25F6AEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award